A detailed history of Stem Point Capital LP transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 132,703 shares of IDYA stock, worth $3.56 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
132,703
Previous 101,787 30.37%
Holding current value
$3.56 Million
Previous $3.57 Billion 17.64%
% of portfolio
1.26%
Previous 1.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$30.37 - $43.05 $938,918 - $1.33 Million
30,916 Added 30.37%
132,703 $4.2 Billion
Q2 2024

Aug 13, 2024

BUY
$34.37 - $43.46 $494,721 - $625,563
14,394 Added 16.47%
101,787 $3.57 Billion
Q1 2024

May 13, 2024

BUY
$34.2 - $47.13 $2.99 Million - $4.12 Million
87,393 New
87,393 $3.83 Billion

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.29B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Stem Point Capital LP Portfolio

Follow Stem Point Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stem Point Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Stem Point Capital LP with notifications on news.